@Sara_from_Sask
🇨🇦 Canadian Prairie Girl 🇨🇦
Petition e-6488 - Petitions
Petition e-6488 - Petitions
Petition e-6619 - Petitions
Petition e-6619 - Petitions
Find Your Elected Rep - On Canada Project
Find Your Elected Rep - On Canada Project
Saskatchewan Critical Care Guidelines
Saskatchewan Critical Care Guidelines
Doses administered world wide
Doses administered world wide
Explore data on COVID-19 vaccinations across the world.
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respira...
Covid Reinfection Risk Study
Covid Reinfection Risk Study
This report describes COVID-19 reinfection among vaccinated and unvaccinated persons in Kentucky.
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-1
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-1
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Ivermectin for preventing and treating COVID-1
Ivermectin for preventing and treating COVID-1
Phase three safety and efficacy of AstraZeneca
Phase three safety and efficacy of AstraZeneca
Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full...
AstraZeneca Animal Trial
AstraZeneca Animal Trial
There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective efficacy of a SARS-CoV-2 subunit vaccine (NVX-CoV2373) produced from the full-length SARS-CoV-2 spike (S) glycoprotein stabiliz …
Phase three safety and efficacy trial data on Moderna
Phase three safety and efficacy trial data on Moderna
Moderna Animal Study
Moderna Animal Study
Phase 3 safety and efficacy trial data on Pfizer
Phase 3 safety and efficacy trial data on Pfizer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe ...
Phase three safety and efficacy of Pfizer 12-15
Phase three safety and efficacy of Pfizer 12-15
Until very recently, vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had not been authorized for emergency use in persons younger than 16 years of age. Safe, effective...
Pfizer Animal Study
Pfizer Animal Study
A safe and effective vaccine against COVID-19 is urgently needed in quantities that are sufficient to immunize large populations. Here we report the preclinical development of two vaccine candidates (BNT162b1 and BNT162b2) that contain nucleoside-modified messenger RNA that encodes immunogens derive …
Coronavirus disease 2019 vaccine response in pregnant and lactating women
Coronavirus disease 2019 vaccine response in pregnant and lactating women
Pregnant and lactating women were excluded from initial coronavirus disease 2019 vaccine trials; thus, data to guide vaccine decision making are lacking.
Long term effects of vaccines
Long term effects of vaccines
Zika - Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
Zika - Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
The Disinformation Dozen
The Disinformation Dozen
Byram Bridle - Spike protein is Toxic
Byram Bridle - Spike protein is Toxic
Reuters fact check on Byram Bridle
Reuters fact check on Byram Bridle
Reuters-Did all the animals die?
Reuters-Did all the animals die?
Katalin Kariko - mRNA Trailblazer
Katalin Kariko - mRNA Trailblazer
Did Robert Malone invent mRNA?
Did Robert Malone invent mRNA?
Robert and Jill Malone chase clout in the comments
Robert and Jill Malone chase clout in the comments
Source of the 1% reporting to VAERS myth
Source of the 1% reporting to VAERS myth
Genomic sequencing of SARS-COV-2
Genomic sequencing of SARS-COV-2
Health Canada approval of vaccines
Health Canada approval of vaccines
The difference between EUA and full authorization from FDA
The difference between EUA and full authorization from FDA
70 studies on mask efficacy
70 studies on mask efficacy
View on mobile
